510(k) K143189
K143189 is an FDA 510(k) premarket notification submitted by Tandem Diabetes Care, Inc. for the device "t:flex Insulin Delivery System". The FDA issued a decision of Substantially Equivalent on January 9, 2015. The device falls under product code LZG (Pump, Infusion, Insulin), a Class II device regulated under 21 CFR 880.5725. Tandem Diabetes Care, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 9, 2015
- Date Received
- November 5, 2014
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Pump, Infusion, Insulin
- Device Class
- Class II
- Regulation Number
- 880.5725
- Review Panel
- CH
- Submission Type